In improved patients, the proportions of CD4+ TCM (P = 0.021) and CD4+ TEM (P = 0.003) cells expressing CD127 were significantly increased after ALSS treatment (Fig. 2E). This evidence concerns the gene CD4 and Alstrom syndrome.